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Abstract
Background: Although intima-media thickness (IMT) was increased in several inflammatory diseases, studies
investigating whether the inflammatory processes lead to macrovascular alteration with increased IMT in complex
regional pain syndrome (CRPS) lack.
Methods: Using ultrasound (high-resolution B-mode), we compared bilaterally the IMT of the common carotid
artery (CCA-IMT), the radial artery (RA-IMT), the brachial artery (BRA-IMT) and the quotient QRA/CCA, in CRPS type I
(n=17), peripheral nerve injury (PNI, n=17) and pain-free controls (PFC, n=22, matched to CRPS by gender, age and
traditional cardiovascular risk factors). Statistics: Spearman’s correlation, paired t-test, ANOVA (p<0.05).
Results: Compared to PFC, RA-IMT were significantly increased in both patient groups bilaterally (mean±standard
deviation, CRPS affected side vs. PFC dominant side: 0.32±0.08 mm vs. 0.19±0.08 mm, p<0.001; PNI affected side vs.
PFC dominant side: 0.27±0.09 mm vs. 0.19±0.08 mm, p< 0.05; CRPS non-affected side vs. PFC non-dominant side:
0.30±0.10 mm vs. 0.19±0.09 mm, p<0.001; PNI non-affected side vs. PFC non-dominant side: 0.25±0.10 mm vs. 0.19
±0.09 mm, p<0.05) and QRA/CCA (CRPS affected-side vs. PFC dominant side: 0.49±0.12 vs. 0.30±0.11, p<0.001; PNI
affected side vs. PFC dominant side: 0.41±0.10 vs. 0.30±0.11, p<0.05; CRPS non-affected side vs. PFC non-dominant
side: 0.43±0.19 vs. 0.30±0.13, p<0.001; PNI non-affected side vs. PFC non-dominant side: 0.39±0.14 vs. 0.30±0.13,
p<0.05), and BRA-IMT - only on the affected side in CRPS (CRPS: 0.42±0.06 mm vs. PFC: 0.35±0.08 mm; p<0.05). In
CRPS, QRA/CCA was significantly higher on the affected side compared to PNI (p<0.05). However, only CRPS
displayed within-group side-to-side differences with a significantly increased RA-IMT and QRA/CCA on the affected
side (p<0.05). The CCA-IMT was comparable between all groups and sides.
Conclusions: The increased IMT of peripheral arteries in CRPS suggests ongoing inflammatory process. Until now,
only endothelial dysfunction has been reported. The presented morphological macrovascular alterations might
explain the treatment resistance of some CRPS patients.
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Background
Complex regional pain syndrome type I (CRPS I) occurs
as a severe complication after limb trauma without evi-
dence of a peripheral nerve lesion. At the beginning of the
disease patients present signs and symptoms like pain,
edema, increased skin temperature and redness [1]. The
underlying pathomechanisms of CRPS are still unclear,
but the clinical signs and symptoms as well as other fin-
dings indicate the involvement of inflammatory processes
for the development of CRPS [2]. For example, locally
increased levels of pro-inflammatory cytokines like tumor
necrosis factor alpha (TNF-α) and interleukin-6 (IL-6)
were found in the affected limb of CRPS patients com-
pared to the non-affected limb [3]. Furthermore, the sys-
temic mRNA levels of some anti-inflammatory cytokines
(interleukin-10) were decreased [4], whereas the systemic
levels of pro-inflammatory neuropeptides including cal-
citonin gene-related peptide, bradikinin and substance P
were increased [2]. Moreover, higher levels of endothelin-
1, but low levels of nitric oxide have been described [5].
Furthermore, in CRPS patients with allodynia the concen-
tration of plasma neuropeptid Y was lower on the painful
side [6]. Additionally, lower concentration of plasma nora-
drenalin was found in CRPS patients with widespread
allodynia as well as in those with hyperhidrosis [7].
Increased intima-media thickness (IMT), measured by
high-resolution ultrasound, is a non-invasive marker of
early arterial wall alteration. It can result from cardio-
vascular risk factors such as smoking, hypertension, dia-
betes mellitus and hypercholesterolemia. Anyway, it may
not necessarily reflect pathologic changing because it is
closely correlated to age [8]. However, an increased IMT
of the common carotid artery (CCA-IMT) is directly asso-
ciated with an increased risk of cardiovascular disease and
its measurement is well accepted for clinical research [9].
Furthermore, there is a strong link between inflamma-
tory markers and increased internal carotid IMT [10].
TNF-α and an increased CCA-IMT were not only posi-
tively associated in healthy middle-aged men [11] but also
with inflammatory markers in different autoimmune dis-
eases including rheumatoid arthritis [12], HIV-infected
patients [13] or in patients with diabetes mellitus [14].
Modern high-resolution ultrasound systems can depict
the macrovascular structure (and change) of intima-media
thickness. To our knowledge, there are no studies on the
IMT in CRPS, although, there are several reports of mic-
rovascular alterations in this disease, e.g. endothelial swel-
ling and changes in the vessel luminal wall detected in a
bone biopsy [15]. Furthermore, hypertrophic changes of
the basal membrane layers of the capillaries were found in
muscle tissue of CRPS patients, analyzed by light and elec-
tronic microscopy [16]. Additionally, in CRPS-affected
skin the denerved vessels were hypertrophied with an
increased size of lumen and thickened multi-laminated
walls [17] and the number of migrated endothelial cells
was increased [18].
The objective of the present prospective study was
to investigate morphologic macrovascular alterations in
patients with unilateral CRPS of the upper extremity by
assessing the IMT of the radial, brachial and common
carotid artery bilaterally in comparison to patients with
unilateral peripheral nerve injury and matched pain-free
controls using high-resolution ultrasonography.
Methods
Patients and pain-free controls
The study was approved by the local Ethics Committee of
the Ruhr University Bochum, Germany (registration num-
ber: 3513–09). All subjects gave their written informed
consent. 26 patients with the diagnosis CRPS type I of the
upper extremity were recruited from the Pain Clinic of
the University Hospital Bergmannsheil Bochum, Germany
(February 2010 to September 2011). The diagnosis was
made by two pain specialists (CM and EK) according to
the clinical Budapest criteria (CRPS characteristics present
in at least 3 of 4 symptom categories and at least 2 of 4
sign categories) [1]. All patients presented pain and dys-
function, which were disproportional to the inciting event,
increased by movement of the affected limb and could not
be explained by another disease. Additionally, all patients
demonstrated the characteristic pattern of an enhanced
bone metabolism in the late phase of a 99-m technetium-
3-phase bone scintigraphy [19]. CRPS type II was exclu-
ded based on the absence of electromyographic and/or
nerve conduction abnormalities. Furthermore, exclusion
criteria were peripheral arterial obstructive disease stage
IIb - IV by Fontaine, other morphological or functional
vascular disease with impact on the affected extremity,
advanced heart disease with angina pectoris stage III and
IV according to the Canadian Cardiovascular Society,
medication with direct vasodilatators, organic nitrate and
molsidomin, sympatholytic drugs and vasoactive sub-
stances for circulation-promotion. The examination was
aborted in nine of the 26 initially studied CRPS patients
due to severe pain; most of them had longer lasting di-
sease duration and were resistant to the common CRPS
treatment, resulting in strong pain and limited hand func-
tion. Thus, finally 17 patients with unilateral CRPS I were
compared to two control groups. Table 1 summarizes all
relevant clinical data.
For the first control group 19 patients with PNI were
recruited from the Pain Clinic of the University Hospital
Bergmannsheil Bochum, Germany (February 2010 to
September 2011). The diagnosis of unilateral peripheral
nerve injury was made by experienced neurologists by
history and extensive clinical and neurophysiological
examination. Clinical examination included sensory ab-
normalities and motor deficits referring to the skin
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region and muscles innervated by the affected nerve.
The diagnosis was approved by nerve conduction ab-
normalities and the present signs and symptoms were
sufficiently explained by the nerve injury (Table 1). Elec-
troneurographic findings were classified abnormal in
case of a reduction of sensory or motor nerve conduc-
tion velocities, distal motor latencies, a prolongation of
F-wave-latencies, a reduction or absence of the ampli-
tude of compound motor action potentials after distal
motor nerve stimulation or sensory nerve stimulation or
if conduction blocks were present. Reference values are
shown in Table 2. The exclusion criteria were the same
as for the CRPS patients. Examination was aborted in
two of the 19 initially studied PNI patients due to severe
pain during the examination. Thus, 17 PNI patients were
included and compared to 17 CRPS patients. In the two
patient groups both affected as well as unaffected ex-
tremities were measured.
22 pain-free controls (PFC) served for a second con-
trol group. They were recruited from February 2010
until January 2011 among students, hospital staff or their
relatives and were matched to the CRPS patients by gen-
der, age (± five years) and common cardiovascular risk
factors (cigarette smoking, diabetes mellitus, hyper-
tension and hypercholesterolemia). Except from the









Gender (female, n (%)) 8 (47%) 11 (65%) 12 (55%)
Age (years) 53 ± 14 53 ± 14 52 ± 13
Affected side (right),
n (%)
11 (66%) 10 (60%)













Fracture 6 (36%) 1 (6%)
Crush injury 4 (24%) 8 (48%)




Other 1 (6%) -
Current analgesics, n°
No medication 4 (24%) 7 (42%)
Opioids 7 (42%) 6 (36%)
Tricyclic
Antidrepressants
3 (18%) 6 (36%)
Anticonvulsants 6 (36%) 8 (48%)
Coxibs 5 (30%) 2 (12%)
Other non-opioid
analgesics
9 (54%) 4 (24%)
Cardiovascular risk
factors, n (%)°
Current smoker 4 (24%) 6 (36%) 5 (23%)
Past smoker 3 (18%) 3 (18%) 2 (9%)
Arterial hypertension 3 (18%) 5 (30%) 3 (14%)
Diabetes mellitus
Typ I - 2 (12%) -
Typ II 1 (6%) 1 (6%) 1 (5%)




None 6 (36%) 5 (30%) 11 (50%)
One factor 10 (60%) 6 (36%) 10 (45%)
Two factors 1 (6%) 5 (30%) 1 (5%)
Three factors - 1 (6%) -
Table 1 Clinical data (Continued)
Pain duration (months) 16 ± 13
(4. . .60)#
97 ± 12 (4. . .360)#
Patients < 12 months
pain duration, n (%)












Sensory 14 (82%) 13 (77%)
Vasomotor 11 (65%) 8 (48%)
Sudomotor/edema 14 (82%) 7 (42%)
Motor/trophic 17 (100%) 15 (90%)
Patients with positive
sign categories, n (%) ° *
Sensory 13 (78%) 12 (72%)
Vasomotor 11 (66%) 7 (42%)
Sudomotor/edema 14 (82%) 5 (30%)
Motor/trophic 17 (100%) 15 (88%)
Numeric values are in mean ± SD (range). Percentage values refer to the
columns. # p<0.001 (Mann–Whitney U-test). CRPS: complex regional pain
syndrome; NRS: numeric rating scala. ° Multiple answers possible. * According
to the Budapest-criteria [1].
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matched cardiovascular risk factors all subjects were
healthy without a history of trauma, neurological, vascular
or inflammatory disease. After performing the Edinburgh
inventory for assessment of handedness with the PFC
group, the dominant hand was defined as test side
(analogue to the affected side in the patients). Thus, the
dominant side of the healthy subjects was compared to
the affected side of both patient groups and the non-
dominant side was compared to the non-affected side of
both patient groups [20].
While performing the measurements the sonographer
was not blinded to the clinical information.
Investigations and measurements
To avoid inter-observer variability the study measure-
ments were restricted to one examiner (ND) and were
performed after a training phase with twenty other sub-
jects with an experienced sonographer (TM). The cor-
relation between the results obtained from TM and ND
was analyzed with Spearman’s rank correlation coeffi-
cients (r=0.958, p<0.0001). A Bland-Altman-analysis
showed no significant differences.
Intima-media thickness (IMT)
IMT measurements were performed on the subjects
lying in supine position with the head in neutral po-
sition. The arms were in a slightly abducted, resting
position with unclenched hands. A high-resolution ultra-
sound-system with a linear array was used (Sonosite
Erlangen, Germany, HFLx38 13-6MHz). IMT-far-wall-
measurements of the CCA were bilaterally performed
according to the Mannheim-Consensus-protocol [21]
using the SonoCalc-IMT-Software (version 4.1; long-
axis-view of the CCA, one cm distal the bulb in a region
free of plaques). The IMT is defined as the distance bet-
ween the beginning of the tunica intima (far wall) and the
beginning of the tunica adventitia. For reproducible mea-
surements a high-quality image acquisition was used along
a minimum length of 10 mm of an arterial segment as
required [21]. The mean IMT was calculated by three con-
secutive examinations. IMT-far-wall-measurements of the
brachial and radial artery were performed on both sides in
a similar manner like those of the CCA (linear-probe set
to highest resolution (Sonosite HFLx38 13-6MHz), So-
noCalc-IMT-Software, multiple automatic measurements
on 1 cm IMT). The BRA-IMT-measurements were per-
formed while subjects were lying in supine position, the
arm slightly abducted and rotated in resting position with
unclenched hand (most comfortable position for study
subject and investigator). Three consecutive examinations
in long-axis-view of the BRA were performed bilaterally,
whereas the linear array was positioned about 3–5 cm
proximal the elbow. RA-IMT measurements were per-
formed in the same manner. The transducer was posi-
tioned in the distal third of the forearm.
Quotient of the IMT of the radial and carotid artery (QRA/CCA)
Increased CCA-IMT is directly associated with genera-
lized atherosclerosis. To eliminate the impact of athe-
rosclerotic diseases, we generated the QRA/CCA as a
quotient (Q) of the IMT of the radial (RA) and common
carotid artery (CCA):
QRA=CCA ¼ RA IMT mmð ÞCCA IMT mmð Þ
Statistical analysis
For statistical analysis the StatisticaW-Software was used
(StatSoftW Inc., Tulsa, Oklahoma, USA). P-values <0.05
were considered statistically significant, p-values <0.01
highly significant. Descriptive statistics were performed
for all variables. Mann–Whitney-U-test was performed
to compare metric variables (e.g. age, duration of di-
sease, pain intensity). Shapiro-Wilks W-Test was used to
test normal distribution of the parameters. After con-
firming normal distribution for all IMT-values using the
Shapiro-Wilks W-Test, t-test for paired samples was
conducted to investigate body side differences within the
groups. Group comparisons of each body side were ana-
lyzed using a one-way analysis of variance (ANOVA).
Levene’s test was performed to assess the equality of
variance between the different samples. The post-hoc
test (LSD) was performed to detect significant group dif-
ferences. The correlations between mean IMT and




























Nerve conduction studies were classified as pathologic if the results were
below these reference values. CMAP indicates compound muscle action
potential; SNAP, sensory nerve action potential.
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disease duration and pain intensity were analyzed with
Spearman’s rank correlation coefficients.
Results
Clinical data
The gender proportion, the mean age and the number of
cardiovascular risk factors were comparable between the
three groups. The proportion of patients with affection
of the right or left hand as well as the reported current
and maximal pain intensity were also similar in both pa-
tient groups. CRPS patients had a significantly shorter
duration of disease (p<0.001) compared to patients with
PNI. The pain duration was less than 12 months in only
one patient of the PNI group vs. ten of the CRPS
patients (p<0.001, Table 1).
Mean common carotid intima-media thickness
The mean CCA-IMT was similar in all groups and sides
(CRPS affected vs. non-affected side: 0.69±0.19 mm vs.
0.67±0.18 mm, n.s.; PNI affected vs. non-affected side:
0.66±0.12 mm vs. 0.65±0.11 mm, n.s.; PFC dominant vs.
non-dominant side: 0.64±0.12 mm vs. 0.63±0.11 mm, n.s.)
(Table 3). An additional table file shows these data in
more detail (see Additional file 1: Table S1).
Mean brachial intima-media thickness
Mean brachial IMT (BRA-IMT) was significantly increased
on the affected side only in CRPS patients compared to
PFC (0.42±0.06 mm vs. 0.35±0.08 mm, p: <0.05) (Table 3,
Figure 1). There were no side differences in any of the
groups (CRPS affected vs. non-affected side: 0.42±0.06 mm
vs. 0.39±0.12 mm, n.s.; PNI affected vs. non-affected side:
0.40±0.08 mm v.s. 0.39±0.09 mm, n.s.; PFC dominant vs.
non-dominant side: 0.35±0.08 mm vs. 0.33±0.09 mm, n.s.;
Additional file 1: Table S1).
Mean radial intima-media thickness
The mean RA-IMT was significantly increased bilaterally
in both patient groups in comparison to PFC without
differences between the patient groups (CRPS affec-
ted side vs. PFC dominant side: 0.32±0.08 mm vs. 0.19±
0.08 mm, p<0.001; PNI affected side vs. PFC dominant
side: 0.27±0.09 mm vs. 0.19±0.08 mm, p< 0.05; CRPS non-
affected side vs. PFC non-dominant side: 0.30±0.10 mm vs.
0.19±0.09 mm, p<0.001; PNI non-affected side vs. PFC
non-dominant side: 0.25±0.10 mm vs. 0.19±0.09 mm,
p<0.05) (Table 3, Figure 2). Only in CRPS patients the
mean RA-IMT of the affected side was significantly
increased compared to the non-affected side (p<0.05)
(Figure 2, Additional file 1: Table S1).
Quotient of the IMT of the radial and carotid artery (QRA/CCA)
In CRPS patients the QRA/CCA was significantly higher on
the affected side compared to the affected side in PNI
patients (p<0.05) (Table 3, Figure 3). The QRA/CCA was
significantly increased bilaterally in both CRPS and PNI
compared to PFC (CRPS affected-side vs. PFC dominant
side: 0.49±0.12 vs. 0.30±0.11, p<0.001; PNI affected side
vs. PFC dominant side: 0.41±0.10 vs. 0.30±0.11, p<0.05;
CRPS non-affected side vs. PFC non-dominant side: 0.43±
0.19 vs. 0.30±0.13, p<0.001; PNI non-affected side vs. PFC
non-dominant side: 0.39±0.14 vs. 0.30±0.13, p<0.05)
(Table 3, Figure 3). Only in CRPS patients the QRA/CCA of
the affected side was significantly increased compared to
the non-affected side (p< 0.05) (Figure 3, Additional file 1:
Table S1).






CCA-IMT mean affected side (mm) n.s.
CCA-IMT mean non-affected side (mm) n.s.
BRA-IMT mean affected side (mm) <0.05 °
BRA-IMT mean non-affected side (mm) n.s.
RA-IMT mean affected side (mm) <0.01 #,+
RA-IMT mean non- affected side (mm) <0.01 #,+
QRA/CCA affected side <0.01 *, #, +
QRA/CCA non-affected side <0.01 #, +
* CRPS vs. PNI, p<0.05; # CRPS vs. PFC, p<0.001; ° CRPS vs. PFC, p<0.05; + PNI
vs. PFC, p<0.05. CRPS: patients with complex regional pain syndrome; PNI:
patients with peripheral nerve injury; PFC: pain-free controls. CCA: common
carotid artery; BRA: brachial artery; RA: radial artery; IMT: intima-media
thickness; QRA/CCA: Quotient of the IMT of the radial and carotid artery.
Figure 1 Box-plot of the intima-media-thickness of the brachial
artery (BRA-IMT); (mean ± standard deviation; 95% confidence
interval). # p<0.05 (ANOVA). PFC: pain-free controls; PNI: patients
with peripheral nerve injury; CRPS: patients with complex regional
pain syndrome. PFC group: dark grey boxes: non-dominant side,
light grey boxes: dominant side; patients groups: dark grey boxes:
non-affected side, light grey boxes: affected side.
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Correlation between IMT and disease duration and pain
intensity for both patient groups
CCA-IMT, BRA-IMT and RA-IMT did neither correlate
with disease duration nor with pain intensity in the
CRPS group and PNI group.
Discussion
To our knowledge, this is the first study revealing mor-
phological macrovascular alterations in CRPS patients
measured by ultrasonography. The RA-IMT and the
QRA/CCA were increased bilaterally compared to pain-
free controls (PFC) both in CRPS and in PNI patients.
The BRA-IMT of the affected side was increased only in
CRPS patients compared to PFC. CRPS patients had a
significantly higher QRA/CCA on the affected side com-
pared to PNI patients. Only in CRPS the QRA/CCA and
RA-IMT of the affected side were increased compared
to the non-affected side. The CCA-IMT did not differ
between all groups and sides.
Carotid IMT measurement by B-mode ultrasound is a
common, reproducible and well accepted technique to
evaluate the vascular status of patients [9]. In contrast to
the carotid artery, peripheral IMT measurements have
not been well established yet, probably due to difficulties
in measuring the very small radial IMT-values (mean
RA-IMT of 0.19±0.08 mm compared to 0.64±0.12 mm of
the CCA-IMT in our pain-free controls). Unfortunately,
the used software allowed no post-examination mea-
surement of the intima-media-thickness. Therefore the
blinding of assessment was impossible. However, Ku
et al. demonstrated that RA-IMT ultrasound using fre-
quencies of 12 MHz (13 MHz in the present study) is
feasible and produced significant correlations to histo-
logical examinations [22]. There are only a few other
studies of RA-IMT [22,23] or BRA-IMT[24] measure-
ments that use ultrasound. Despite this limited ex-
perience, RA-IMT above 0.25 mm is regarded to be
increased [22]. The mean RA-IMT of our PFC group
was is in the same range of normotensive subjects as
previously reported (0.19±0.02 mm) [23] and the mean
RA-IMT of our patient groups were above or equal to
0.25 mm, indicating the validity of our RA-IMT results.
To eliminate the impact of atherosclerotic diseases we
generated the QRA/CCA and matched our pain-free controls
to CRPS patients on cardiovascular risk factors as well as
age. Age for itself leads to an increase of 0.010 mm/y in the
CCA both in males and females [25]. However, there were
no significant differences in age between the groups in the
present study; therefore, IMT differences between the
groups cannot be solely explained by age effects.
Several studies have observed functional vascular abnor-
malities in CRPS [26], e.g. impaired endothelial function
demonstrated using acetylcholine- and sodium nitropru-
sside-induced vasodilation combined with laser Doppler
flowmetry [27]. In contrast, only a few authors described
morphological abnormalities in the microvascular system.
Our results of increased RA- and BRA-IMTare in line with
the previously described microvascular alterations such as
endothelial swelling and changes in the vessel luminal
wall found in a human bone biopsy [15]; furthermore,
Figure 2 Box-plot of the intima-media-thickness of the radial
artery (RA-IMT); (mean ± standard deviation; 95% confidence
interval). + p<0.05 (ANOVA); # p<0.001 (ANOVA); § p<0.05 (t-test for
paired sample). PFC: pain-free controls; PNI: patients with peripheral
nerve injury; CRPS: patients with complex regional pain syndrome.
PFC group: dark grey boxes: non-dominant side, light grey boxes:
dominant side; patients groups: dark grey boxes: non-affected side,
light grey boxes: affected side.
Figure 3 Box-plot of the quotient of the intima-media
thickness of the radial and carotid artery (QRA/CCA); (mean ±
standard deviation; 95% confidence interval). + p<0.05 (ANOVA);
# p<0.001 (ANOVA); * p<0.05 (ANOVA); § p<0.05 (t-test for paired
sample). PFC: pain-free controls; PNI: patients with peripheral nerve
injury; CRPS: patients with complex regional pain syndrome. PFC
group: dark grey boxes: non-dominant side, light grey boxes:
dominant side; patients groups: dark grey boxes: non-affected side,
light grey boxes: affected side.
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extraordinary vascular hypertrophy characterized by se-
verely thickened multi-laminated walls was found through
immunohistochemical analysis of CRPS-affected skin [17]
or an increased number of migrated endothelial cells [18].
Beside the vascular changes, there is also some evidence
for inflammatory alterations in CRPS patients [3,4] and
the important role of inflammatory processes for the de-
velopment of this disease [2], including increased local
concentration of inflammatory markers in the affected ex-
tremity of CRPS patients [3,4]. However, only a few stud-
ies give hints not only for local but also for systemic
inflammatory processes in CRPS [28,29], such as increased
levels of IL-8 and tumor-necrosis-factor receptor I/II in
the affected arm of patients with acute CRPS I without
significant differences compared to the non-affected arm
[29]. Six years after disease onset the difference of TNF-α
and IL-6-levels between the affected and the non-affected
side was not significant anymore [28].
We hypothesize, that an increased IMT in CRPS patient
is a sign of inflammatory processes. Unfortunately, we did
not measure inflammatory mediators in the serum in our
patients. However, we found a significantly increased ra-
dial IMT in the affected side compared to the non-
affected side, in line with the previously reported high
local concentration of inflammatory markers only in the
affected extremity [3]. In accordance with these local fin-
dings we have observed unilaterally increased BRA-IMT
only on the affected side. Similarly to the clinical signs
and symptoms, which are presented mainly in the distal
part of the affected limb, we have also observed a gradient
in the macrovascular changes, which were more pro-
nounced on the distal than on the proximal limb: The
CCA-IMT was bilaterally not increased, while we found
an unilateral moderate increase in the BRA-IMT and a
more pronounced increase in the RA-IMT suggesting a
local process in the distal limb. However, also the radial
IMT of the non-affected side was significantly increased
compared to PFC without having any signs or symptoms
on that side, which could be in accordance with previous
results indicating a systemic process. Merely in CRPS
patients not only radial IMT but also brachial IMT was
significantly increased in the affected side compared to
PFC. However there was no significant difference between
the affected and non-affected side, which is a further hint
for a systemic process. However, the maximal IMT alter-
ation in our study is located at the radial artery on the
affected side. Even though our controls were matched to
age, gender and risk factors, we found the highest
QRA/CCA in CRPS patients indicating disease specific altera-
tions. Thus, our findings suggest both a systemic and local
inflammatory process. According to our hypothesis that
inflammation might induce increased IMT in CRPS,
several studies demonstrated the association between
inflammatory markers such as TNF-α or IL-6 and an
increased IMT of the CCA [10-12,14]. In contrast, to our
knowledge there are no studies that examined the corre-
lation between inflammatory signs and increased radial or
brachial IMT.
Unexpectedly, we found an increased RA-IMT also in
the PNI group compared to PFC, however without signifi-
cant side differences in contrast to the CRPS group. In
painful peripheral neuropathies significantly higher blood
levels of IL-2 mRNA and TNF-α mRNA were measured
compared to healthy subjects [30]. Furthermore, changes
in plasma cytokines (IL-2, TNF) after nerve injury have
been described [31]. To our knowledge, there are no stu-
dies which have observed intima-media thickening in
patients with nerve injury. Although in our study the IMT
of PNI patients was also increased, CRPS patients dis-
played the highest IMT. This was also supported by a sig-
nificantly higher QRA/CCA of the affected side in CRPS
patients compared to PNI patients.
It is important to notice that CRPS patients had sig-
nificantly shorter mean disease duration than PNI
patients. In only one patient of the PNI group vs. ten of
the CRPS group the pain duration was less than 12
months. However, the disease duration in both groups
was widely ranging (4–60 months in CRPS; 4–360
months in PNI), but neither CCA-IMT, nor BRA-IMT
or RA-IMT correlated with disease duration in both pa-
tient groups. In other inflammatory diseases there was a
positive correlation between disease duration and IMT
[32]. However, there are hints that carotid intima-media
thickening and radial wall hypertrophy are reversible
[33]. We did not find a correlation between IMT and
pain intensity probably because all our patients received
a pain treatment and we did not included an untreated
control group. Moreover, nine CRPS and two PNI
patients were excluded from our study due to the impos-
sibility to perform the ultrasound scan because of severe
hyperalgesia and allodynia. Thus, these dropout-patients
may result in an underestimation of our findings. How-
ever, assuming that the intima-media thickening results
from inflammatory processes, our findings are in line
with previous studies reporting absent correlation bet-
ween inflammatory mediators and clinical course or out-
come with high interindividual variation [34]. In our
study it was impossible to prove the association between
clinical signs and IMT because clinical signs were pre-
sented by nearly or more than 80% of the CRPS patients
except from vasomotor signs (Table 1). However, pa-
tients with or without vasomotor signs did not show a
difference in all mean IMT-values.
Our study was a cross-sectional analysis which served
as a pilot project and which may not clarify completely
the correlation of IMT-alterations and disease duration,
pain intensity or clinical signs and symptoms by now.
Even though the benefit of long-term measurement of
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carotid IMT progression to predict cardiovascular events
is still under debate [35], longitudinal radial artery scan
studies in CRPS within the first year after disease onset
are necessary at the next step, having in mind the fast
disease progression. Longitudinal studies are needed to
analyze the time course of these alterations from the
early to later stages of the disease as well as to examine
whether an increased IMT of CRPS patients is reversible
and, in case it is, if this reversibility is accompanied by
clinical improvement. Repeated IMT-measurements may
be used to test the effectiveness of CRPS-treatment. Fu-
ture studies should also be combined with measure-
ments of inflammatory mediators to prove a possible
association between increased IMT and inflammatory
markers. However, it should be considered that IMT
measurements are limited by hyperalgesia and allodynia
in CRPS patients as well as by the need for a physician
with profound skills in sonography. In addition to that,
our unexpected observation of locally enlarged IMT in
PNI patients should be reevaluated in patients with dif-
ferent types of nerve injury with a greater sample size
and with simultaneously measurements of inflammatory
markers.
Conclusion
In conclusion, we examined macrovascular alterations in
CRPS patients using high-resolution sonography demon-
strating for the first time bilaterally increased radial and
unilaterally increased brachial IMTs. Further longitudinal
studies are required to prove whether these alterations
can be used as diagnostic or prognostic markers.
Additional file
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